Carlos Bueso-Ramos

Carlos Bueso-Ramos

UNVERIFIED PROFILE

Are you Carlos Bueso-Ramos?   Register this Author

Register author
Carlos Bueso-Ramos

Carlos Bueso-Ramos

Publications by authors named "Carlos Bueso-Ramos"

Are you Carlos Bueso-Ramos?   Register this Author

100Publications

-Reads

Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era.

PLoS One 2018 17;13(9):e0204218. Epub 2018 Sep 17.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

View Article
September 2018

Higher body mass index is associated with better survival in patients with myelodysplastic syndromes.

Leuk Res 2018 Aug 10;71:63-66. Epub 2018 Jul 10.

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States. Electronic address:

View Article
August 2018

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.

J Clin Oncol 2018 Jun 27;36(18):1788-1797. Epub 2018 Apr 27.

Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD Anderson Cancer Center, Houston, TX; Kiyomi Morita, The University of Tokyo, Tokyo; and Koichi Takahashi, Kyoto University, Kyoto, Japan.

View Article
June 2018

Bone marrow findings in blast phase of polycythemia vera.

Ann Hematol 2018 Mar 28;97(3):425-434. Epub 2017 Dec 28.

Department of Hematopathology, Unit 0072, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article
March 2018

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.

J Hematol Oncol 2018 Mar 15;11(1):42. Epub 2018 Mar 15.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article
March 2018

Acute myeloid leukemia with t(4;12)(q12;p13): an aggressive disease with frequent involvement of and .

Oncotarget 2018 Feb 15;9(13):10987-10994. Epub 2017 Dec 15.

Department of Hematopathology, Tianjin First Center Hospital, Tianjin, China.

View Article
February 2018

Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

Exp Hematol Oncol 2017 9;6:30. Epub 2017 Nov 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 428, Houston, TX 77030 USA.

View Article
November 2017

Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis.

Leuk Lymphoma 2017 10 28;58(10):2508-2510. Epub 2017 Feb 28.

f Department of Hematopathology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article
October 2017

Characteristics and clinical implications of reactive germinal centers in the bone marrow.

Hum Pathol 2017 10 17;68:7-21. Epub 2017 Apr 17.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article
October 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1405-1410. Epub 2017 May 8.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article
August 2017

Progress in Myelodysplastic Syndromes: Clinicopathologic Correlations and Immune Checkpoints.

Clin Lymphoma Myeloma Leuk 2017 07;17S:S16-S25

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article
July 2017

Primary autoimmune myelofibrosis: a case report and review of the literature.

Int J Hematol 2017 Apr 9;105(4):536-539. Epub 2016 Nov 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article
April 2017

Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.

Am J Surg Pathol 2017 Jan;41(1):82-93

*Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston ‡Department of Pathology, UT Southwestern Medical Center, Dallas, TX †Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.

View Article
January 2017

Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report.

Medicine (Baltimore) 2016 Oct;95(41):e4934

aDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX bDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China cDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article
October 2016

Analysis of class I and II histone deacetylase gene expression in human leukemia.

Leuk Lymphoma 2015 26;56(12):3426-33. Epub 2015 May 26.

a Department of Leukemia , University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article
September 2016

Advances in B-lymphoblastic leukemia: cytogenetic and genomic lesions.

Ann Diagn Pathol 2016 Aug 9;23:43-50. Epub 2016 Apr 9.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article
August 2016

High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2016 08 1;16 Suppl:S30-8. Epub 2016 Apr 1.

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article
August 2016

Multiparameter Analysis of Off-Target Effects of Dasatinib on Bone Homeostasis in Patients With Newly Diagnosed Chronic Myelogenous Leukemia.

Clin Lymphoma Myeloma Leuk 2016 08;16 Suppl:S86-92

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article
August 2016

MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.

Histopathology 2016 Jun 8;68(7):1090-8. Epub 2015 Dec 8.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article
June 2016

Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia.

Am J Hematol 2016 Jun 29;91(4):E274-6. Epub 2016 Feb 29.

Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article
June 2016

Aberrant hnRNP K expression: All roads lead to cancer.

Cell Cycle 2016 Jun;15(12):1552-7

a Department of Leukemia , The University of Texas, MD Anderson Cancer Center , Houston , TX , USA.

View Article
June 2016

Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.

Am J Surg Pathol 2016 May;40(5):676-88

Departments of *Hematopathology †Stem Cell Transplantation §Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX #Biostatistics **Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston ¶Department of Pathology, UT Southwestern Medical Center, Dallas, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ∥Department of Pathology, University of Miami, Miami, FL.

View Article
May 2016

Down-regulation of EZH2 expression in myelodysplastic syndromes.

Leuk Res 2016 May 26;44:1-7. Epub 2016 Feb 26.

Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.

View Article
May 2016

Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.

Ann Diagn Pathol 2016 Apr 6;21:53-8. Epub 2016 Feb 6.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States. Electronic address:

View Article
April 2016

Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.

Mol Cytogenet 2016 27;9:23. Epub 2016 Feb 27.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 USA.

View Article
February 2016

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Biol Blood Marrow Transplant 2016 Jan 4;22(1):47-53. Epub 2015 Sep 4.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Transplant Myeloid Study Group, Department of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article
January 2016

Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation.

Cancer Genet 2015 Nov 25;208(11):571-4. Epub 2015 Jun 25.

Department of Pathology, The Ohio State University, Columbus, OH, USA.

View Article
November 2015

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

J Natl Cancer Inst 2015 Nov 13;108(2). Epub 2015 Nov 13.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA (JY, JJ, NJMR, MC, JPJI); Department of Leukemia (JY, RT, JJ, NJMR, SAP, SMK, FR, HMK, JPJI) and Department of Hematopathology (CEBR), The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article
November 2015

Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.

Am J Hematol 2015 Sep 27;90(9):769-73. Epub 2015 Jul 27.

Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article
September 2015

Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1.

Am J Clin Pathol 2015 Sep;144(3):377-92

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston; and

View Article
September 2015

Therapy-Related Myeloid Neoplasms.

Am J Clin Pathol 2015 Aug;144(2):207-18

The Division of Hematopathology, Mayo Clinic, Rochester, MN.

View Article
August 2015

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.

Clin Cancer Res 2015 Jul 16;21(13):3041-51. Epub 2015 Mar 16.

University of New Mexico Cancer Center, University of New Mexico School of Medicine, Albuquerque, New Mexico. Division of Molecular Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico.

View Article
July 2015

Introduction to the 2013 Workshop of the Society for Hematopathology/European Association for Haematopathology.

Am J Clin Pathol 2015 Jul;144(1):4-5

Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.

View Article
July 2015

Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features.

Clin Lymphoma Myeloma Leuk 2015 Jun;15 Suppl:S85-90

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article
June 2015

RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype.

Br J Haematol 2015 May 22;169(3):344-51. Epub 2015 Jan 22.

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article
May 2015

Isolated +15 in bone marrow: disease-associated or a benign finding?

Leuk Res 2015 Jan 15;39(1):72-6. Epub 2014 Nov 15.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article
January 2015

Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.

J Natl Compr Canc Netw 2015 Jan;13(1):19-22

From the Departments of Hematopathology, Leukemia, Genomic Medicine, and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article
January 2015